This renewal continues our previous efforts to better define various elements within the coronary microcirculation that regulate blood flow, and also furthers the elucidation of the signal transduction pathway for flow-induced dilation, which we believe is a response that facilitates communication of metabolic signals throughout the coronary circulation. The first objective is to elucidate a critical factor that is one of the causal links between coronary blood flow and myocardial oxygen consumption. Accordingly, aim 1 test the hypothesis that hydrogen peroxide (H2O2) links coronary blood flow to myocardial metabolism. Our second objective is to elucidate the basis and effects of cardiac myocyte-produced metabolites on endothelial function.
This aim will test the hypothesis that during increased metabolism, cardiac myocytes produce a factor that induces endothelial cell depolarization and decreases NO production. Our third objective is to define the signaling pathway by flow induced EDHF-mediated vasodilation. This last aim will test the hypothesis that the signal transduction pathways for flow-induced EDHF- and NO-mediated dilation are different. Our experimental approach incorporates a variety of techniques including Western analyses of activated proteins to understand signal transduction pathways, patch clamping to identify ionic mechanisms associated with FID, isolated microvessels to elucidate FID transduction pathways, isolated microvessels and myocytes to identify metabolic hyperemic mechanisms, fluorescence microscopy to assess production of reactive oxygen species (ROS), viral transfection of the myocardium, and in vivo studies establishing the link between myocardial metabolism and coronary blood flow. The elucidation of these aims will facilitate our understanding of the causal basis of metabolic hyperemia, the relationships between metabolic and endothelium-dependent dilation, and the mechanotransduction of shear stress leading to EDHF-mediated dilation. This information will greatly aid our understanding of the regulation of coronary blood flow.
| Ohanyan, Vahagn; Yin, Liya; Bardakjian, Raffi et al. (2017) Kv1.3 channels facilitate the connection between metabolism and blood flow in the heart. Microcirculation 24: |
| Guarini, Giacinta; Kiyooka, Takahiko; Ohanyan, Vahagn et al. (2016) Impaired coronary metabolic dilation in the metabolic syndrome is linked to mitochondrial dysfunction and mitochondrial DNA damage. Basic Res Cardiol 111:29 |
| Pung, Yuh Fen; Sam, Wai Johnn; Stevanov, Kelly et al. (2013) Mitochondrial oxidative stress corrupts coronary collateral growth by activating adenosine monophosphate activated kinase-? signaling. Arterioscler Thromb Vasc Biol 33:1911-9 |
| Hardwick, James P; Eckman, Katie; Lee, Yoon Kwang et al. (2013) Eicosanoids in metabolic syndrome. Adv Pharmacol 66:157-266 |
| Pung, Yuh Fen; Sam, Wai Johnn; Hardwick, James P et al. (2013) The role of mitochondrial bioenergetics and reactive oxygen species in coronary collateral growth. Am J Physiol Heart Circ Physiol 305:H1275-80 |
| Chilian, William M; Penn, Marc S; Pung, Yuh Fen et al. (2012) Coronary collateral growth--back to the future. J Mol Cell Cardiol 52:905-11 |
| Yin, Liya; Ohanyan, Vahagn; Pung, Yuh Fen et al. (2012) Induction of vascular progenitor cells from endothelial cells stimulates coronary collateral growth. Circ Res 110:241-52 |
| Pung, Yuh Fen; Rocic, Petra; Murphy, Michael P et al. (2012) Resolution of mitochondrial oxidative stress rescues coronary collateral growth in Zucker obese fatty rats. Arterioscler Thromb Vasc Biol 32:325-34 |
| Belmadani, Souad; Matrougui, Khalid; Kolz, Chris et al. (2009) Amplification of coronary arteriogenic capacity of multipotent stromal cells by epidermal growth factor. Arterioscler Thromb Vasc Biol 29:802-8 |
| Yun, June; Rocic, Petra; Pung, Yuh Fen et al. (2009) Redox-dependent mechanisms in coronary collateral growth: the ""redox window"" hypothesis. Antioxid Redox Signal 11:1961-74 |
Showing the most recent 10 out of 90 publications
